Literature DB >> 16905388

Specimen radiography as predictor of resection margin status in non-palpable breast lesions.

C Mazouni1, R Rouzier, C Balleyguier, L Sideris, F Rochard, S Delaloge, H Marsiglia, M-C Mathieu, M Spielman, J-R Garbay.   

Abstract

AIM: This study aimed to evaluate the role of specimen radiography in predicting margin status for non-palpable breast malignancies.
METHODS: We retrospectively reviewed the clinical and pathological data together with specimen radiographs of 164 women with ductal carcinoma in situ, who were referred to our centre between January 1997 and December 2000. In all cases microcalcifications were discovered on mammography. Lesions were localized preoperatively using a guide-wire. Specimen radiography findings and clinicopathological data were correlated with pathological findings.
RESULTS: Findings comprised 122 pure ductal carcinomas in situ (74%) and 42 mixed carcinomas, both infiltrating and in situ (26%). On the specimen radiographs, the lesions were close (<1mm) to one edge of the lumpectomy in 34 (21%) cases. Histologically, there were 103 positive resection margins (<1mm, 63%) and only 61 negative margins (> or =1mm, 37%). On univariate analysis, factors associated with positive resection margins were found to be distance from microcalcifications to edge of lesion on specimen radiographs, and radiological multifocality. On multivariate analysis (logistic regression), a radiological margin <5mm and multifocality were the only risk factors for close histological margins. Radiological margins were not associated with surgical findings.
CONCLUSION: Our results demonstrate that there is a correlation between specimen radiographs and histological results. The clinical relevance of this should be evaluated in a prospective study.

Entities:  

Mesh:

Year:  2006        PMID: 16905388     DOI: 10.1016/j.crad.2006.04.017

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  6 in total

1.  Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors.

Authors:  Jordan Atkins; Fatema Al Mushawah; Catherine M Appleton; Amy E Cyr; William E Gillanders; Rebecca L Aft; Timothy J Eberlein; Feng Gao; Julie A Margenthaler
Journal:  J Surg Res       Date:  2012-04-10       Impact factor: 2.192

2.  Accuracy of frozen section analysis versus specimen radiography during breast-conserving surgery for nonpalpable lesions.

Authors:  Walter P Weber; Stephan Engelberger; Carsten T Viehl; Rosanna Zanetti-Dallenbach; Salome Kuster; Stephan Dirnhofer; Daniela Wruk; Daniel Oertli; Walter R Marti
Journal:  World J Surg       Date:  2008-12       Impact factor: 3.352

3.  Influence of surgical technique on mastectomy and reexcision rates in breast-conserving therapy for cancer.

Authors:  Alison Unzeitig; Anne Kobbermann; Xian-Jin Xie; Jingsheng Yan; David Euhus; Yan Peng; Venetia Sarode; Amy Moldrem; A Marilyn Leitch; Valerie Andrews; Roshni Rao
Journal:  Int J Surg Oncol       Date:  2012-01-16

4.  Intraoperative Specimen Mammography for Margin Assessment in Breast-Conserving Surgery.

Authors:  Ming Jin; Ji Young Kim; Tae Hee Kim; Doo Kyung Kang; Se Hwan Han; Yongsik Jung
Journal:  J Breast Cancer       Date:  2019-12-20       Impact factor: 3.588

5.  Indications and methods of intraoperative specimen radiography in breast-conserving surgery.

Authors:  Ji Young Kim; Yong Sik Jung; Se Hwan Han; Ji Hyun Sung; Min Hee Hur
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

6.  Does conventional specimen radiography after neoadjuvant chemotherapy of breast cancer help to reduce the rate of second surgeries?

Authors:  Benedikt Schaefgen; Annika Funk; H-P Sinn; Thomas Bruckner; Christina Gomez; Aba Harcos; Anne Stieber; Annabelle Haller; Juliane Nees; Riku Togawa; André Pfob; André Hennigs; Johanna Hederer; Fabian Riedel; Sarah Fastner; Christof Sohn; Jörg Heil; Michael Golatta
Journal:  Breast Cancer Res Treat       Date:  2021-12-08       Impact factor: 4.872

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.